Annual Review of Cancer Biology

Papers
(The TQCC of Annual Review of Cancer Biology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Immune Cell Metabolism and Immuno-Oncology121
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo42
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond38
lncRNAs as Targetable Nodes of Oncogenic Networks Underlying Cancer Progression and Therapy Resistance36
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer36
Mitochondria, OXPHOS, and Cancer Progression: A Modular View32
Lessons from 3D Reconstruction of Cancer28
Natural and Engineered Cytokines as Cancer Therapeutics24
Allogeneic CAR T Cell Therapy for Cancer22
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?21
Beyond Mice and Men: Alternative Vertebrate and Invertebrate Models in Cancer Biology20
Road Map to Defeat Pancreatic Cancer18
They Contain Multitudes: The Diverse Roles of CD4+ T Cells in Cancer Immunity18
Cancer Cell Polarity and Extrusion16
Engineering Cancer with Next-Generation Genome Editing Tools16
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies16
Cancer Dependency Map: Past and Present16
Targeting RAS for Cancer Treatment: What a Long, Strange Trip It's Been15
An Erratic Path Toward Discovery15
The Effects of Clonal Heterogeneity on Cancer Immunosurveillance14
Rationales for Combining Therapies to Treat Cancer: Independent Action, Response Correlation, and Collateral Sensitivity Versus Synergy14
Strategies for Heating Up Cold Tumors to Boost Immunotherapies13
Engineering the Immune Microenvironment into Organoid Models13
The Angiocrine Niche in Cancer Therapy Responses: The Role of Vascular Endothelial Cells in Immunomodulation13
1.1284449100494